3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gynecologic
1
Conditions
Breast Neoplasms
7
Lymphoma, Large B-Cell, Diffuse
5
Lymphoma, Large-Cell, Anaplastic
3
Lymphoma
3
Immunoblastic Lymphadenopathy
3
Esophageal Neoplasms
3
Central Nervous System Neoplasms
3
Burkitt Lymphoma
3
Adenocarcinoma Of Esophagus
3
Stomach Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma
2
Rectal Neoplasms
2
Precancerous Conditions
2
Osteosarcoma
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Multiple Myeloma
2
Lymphoma, T-Cell, Peripheral
2
Lymphoma, Mantle-Cell
2
Lymphoma, Follicular
2
Lymphoma, Extranodal NK-T-Cell
2
Lymphoma, B-Cell, Marginal Zone
2
Lung Neoplasms
2
Liver Neoplasms
2
Leukemia
2
Gliosarcoma
2
Glioblastoma
2
Colorectal Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Interventions
Colposcopy
15
Imiquimod
13
Conization
11
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
7
Cryotherapy
7
Papillomavirus Vaccines
6
Biopsy
6
Acetic Acid
6
human papillomavirus vaccine, L1 type 16, 18
5
Vaginal Smears
5
Watchful Waiting
4
Human Papillomavirus DNA Tests
4
Vaccines
3
Blood Specimen Collection
3
VGX-3100
2
Transurethral Resection of Prostate
2
Spectrometry, Fluorescence
2
Restraint, Physical
2
Proflavine
2
Polymerase Chain Reaction
2
Mass Screening
2
Indomethacin
2
Human Papillomavirus Recombinant Vaccine nonavalent
2
High-Throughput Screening Assays
2
GX-188 vaccine
2
Fluorouracil
2
Flow Cytometry
2
Cyclophosphamide
2
Curcumin
2
Celecoxib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Uterine Cervical Dysplasia
×
Microarray Analysis
×
Clear all
NCT00629577
2017-02-01
SAGE
British Columbia Cancer Agency
Phase 1
Terminated
50 enrolled